Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib vs. Diclofenac in Hip Osteoarthritis Requiring Joint Replacement
NCT00174317Phase 4Completed
- Sponsor
- Pfizer
- Start
- Aug 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of celecoxib in osteoarthritis of the hip (2 arms), sponsored by Pfizer. Primary endpoint: Change in patient assessment of arthritis pain on walking VAS at week 6. Started Aug 2003; status: completed.
02
Drugs
celecoxib
03
Conditions
osteoarthritis of the hip
Beyond the preview
Go deeper on NCT00174317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174317.